Subacute (De Quervain's) Thyroiditis: The Painful Post-Viral Thyroiditis

Subacute thyroiditis (De Quervain's) is a painful post-viral granulomatous thyroiditis with a three-phase course. NSAIDs or short-course prednisone control inflammation; permanent hypothyroidism develops in about 5%.

Why subacute thyroiditis happens

Subacute thyroiditis — also called De Quervain's thyroiditis or granulomatous thyroiditis — is the classic painful thyroiditis. It typically follows a viral upper-respiratory infection by 2 to 8 weeks, and on biopsy the gland shows the hallmark giant-cell granulomas that give the condition its other name [C1][C4].

The mechanism is not direct viral infection of thyroid cells. Instead, the immune response to a recent viral illness produces inflammation that damages thyroid follicles, releasing pre-formed thyroid hormone into the bloodstream all at once [C1]. Because the hormone is leaking out of a damaged gland rather than being newly synthesized, the gland itself is not overactive — radioactive iodine uptake is low, which separates subacute thyroiditis from Graves' disease on imaging [C2].

The trigger is usually a common respiratory virus (coxsackievirus, adenovirus, influenza, mumps, measles have all been implicated) [C1]. Subacute thyroiditis after COVID-19 and rarely after vaccination has also been described in more recent literature [C4]. It is most common in women aged 30 to 50, and has a strong HLA-B*35 genetic association [C1][C4].

Clinical pattern and timeline

The presentation is distinctive enough that a careful clinical history often makes the diagnosis [C1][C4]:

• Recent viral illness 2 to 8 weeks before symptom onset
• Neck pain — often severe, radiating to the jaw, ear, or upper chest, frequently worse with swallowing or turning the head
• Tender, firm, sometimes asymmetric goiter on exam
• Systemic symptoms: low-grade fever, malaise, fatigue, myalgia
• Markedly elevated ESR (often >50 mm/h) and elevated CRP — the lab hallmark
• Low radioactive iodine uptake on scan, distinguishing it from Graves' disease [C2]

The course follows three phases over 4 to 6 months in most patients [C1][C4]:

1. Thyrotoxic phase (weeks 0–6). Stored hormone leaks from the damaged gland. Low TSH, elevated free T4 and free T3, with symptoms of palpitations, tremor, heat intolerance, anxiety, and weight loss.
2. Hypothyroid phase (weeks 6–16). Hormone stores are depleted and the inflamed gland cannot synthesize replacement. TSH rises; free T4 falls. Patients may feel fatigued, cold, constipated, with dry skin.
3. Recovery phase (months 4–6). Inflammation resolves, follicles regenerate, and thyroid function normalizes in about 95% of patients [C4].

Not every patient passes through every phase clinically — some have only the thyrotoxic phase, some glide quietly through hypothyroidism, and many never realize they are cycling through different thyroid states unless labs are drawn.

What recovers on appropriate treatment

The cornerstone of treatment is anti-inflammatory therapy, not thyroid hormone manipulation [C2][C3][C4]. The thyrotoxicosis is self-limited and stops once the gland's hormone stores are exhausted; the goal is to control pain, inflammation, and thyrotoxic symptoms while the gland heals.

• NSAIDs (ibuprofen, naproxen, high-dose aspirin) — first-line. They control pain and inflammation in most mild-to-moderate cases [C2][C3][C4]. The 2016 ATA hyperthyroidism guideline recommends NSAIDs as initial therapy for symptomatic subacute thyroiditis [C2].
• Prednisone — for severe pain or NSAID failure. Typical starting doses are 30 to 40 mg/day, tapered over 4 to 6 weeks. Prednisone produces faster and more complete pain relief than NSAIDs in head-to-head data, but with the cost of steroid side effects and a higher relapse rate when tapered too quickly [C3][C5].
• Beta-blocker (propranolol or atenolol) for the thyrotoxic phase. Controls palpitations, tremor, and anxiety while the leaked hormone clears [C2].
• Levothyroxine if the hypothyroid phase is symptomatic or prolonged — usually a temporary, low-dose course, weaned off and rechecked at 6 to 12 months [C1][C6].

A 2024 systematic review and meta-analysis of 12 studies found steroids produced faster symptom resolution than NSAIDs but had higher recurrence rates and more adverse events, supporting the standard approach of NSAIDs first and prednisone reserved for severe cases [C3]. A 2020 RCT found that 2-week and 6-week prednisone courses had similar efficacy, suggesting shorter tapers are reasonable for many patients [C5].

Most patients recover fully within 4 to 6 months with thyroid function returning to normal [C1][C4].

When permanent hypothyroidism develops

In roughly 5% to 15% of patients, the inflammation leaves enough fibrosis and follicular destruction that the gland cannot fully recover, resulting in permanent hypothyroidism [C1][C4]. This is less common than in painless silent thyroiditis or postpartum thyroiditis, where rates can reach 20% to 50%.

Risk factors for permanent hypothyroidism after subacute thyroiditis include [C4]:

• Older age at onset
• Higher TSH during the hypothyroid phase
• Prolonged hypothyroid phase (>6 months)
• Severe initial inflammation requiring prolonged steroids
• Pre-existing thyroid autoantibodies (rare but worth checking) [C7]

For these patients, lifelong levothyroxine is the standard, and dosing follows the same principles as any hypothyroidism — start low in older or cardiac patients, recheck TSH at 6 to 8 weeks, target the normal range [C6][C8].

Recurrence of subacute thyroiditis is uncommon — roughly 2% to 4% — but more likely in patients tapered off steroids too quickly [C3][C5].

What does NOT help

Subacute thyroiditis attracts a lot of folk-remedy attention because the neck pain is dramatic. The following lack evidence [C2][C3][C4]:

• Antithyroid drugs (methimazole, PTU) — these block hormone synthesis, but in subacute thyroiditis the problem is hormone leakage from a damaged gland. They are not effective and are not recommended [C2].
• Antiviral therapy — by the time symptoms appear, the triggering viral infection has resolved. No trial supports antivirals for subacute thyroiditis [C1].
• Antibiotics — subacute thyroiditis is not a bacterial infection and does not respond to antibiotics. Acute suppurative thyroiditis is a separate, much rarer condition [C1].
• "Anti-inflammatory" diets, herbal teas, or supplements — there is no evidence that turmeric, ashwagandha, sea moss, or other supplements alter the course. Standard NSAIDs work; novel anti-inflammatories do not have data here [C2].
• Long open-ended prednisone courses — extended steroid use beyond 6 to 8 weeks does not reduce permanent hypothyroidism rates and adds cumulative side effects [C3][C5].

Practical guidelines

1. See your endocrinologist early. Severe anterior neck pain with low-grade fever, fatigue, and a tender goiter is a classic enough presentation that an ESR and TSH typically clarify the diagnosis within a day [C1][C4].
2. Expect a three-phase course. Your endocrinologist will check TSH and free T4 every 4 to 6 weeks through recovery to track the transitions [C1][C4].
3. Start with NSAIDs. Ibuprofen or naproxen at standard anti-inflammatory doses controls pain in most cases [C2][C3].
4. Reserve prednisone for severe pain or NSAID failure. A typical course is 30 to 40 mg/day tapered over 4 to 6 weeks [C2][C3][C5].
5. Use a beta-blocker for thyrotoxic symptoms — palpitations, tremor, anxiety — but only as long as the thyrotoxic phase lasts [C2].
6. Recheck TSH at 6 and 12 months to confirm recovery. If TSH stays elevated past 12 months on no medication, your endocrinologist will discuss long-term levothyroxine [C1][C6].

Frequently asked questions

Is the neck pain dangerous? The pain is from inflammation, not infection or cancer. It is genuinely severe in many patients but responds to anti-inflammatory treatment. Your endocrinologist will rule out other causes of neck pain (acute suppurative thyroiditis, thyroid hemorrhage, rapidly enlarging nodule) with exam and labs [C1].

Will I need lifelong thyroid hormone? Most patients recover fully — about 85% to 95% return to normal thyroid function within 6 to 12 months [C1][C4]. Roughly 5% to 15% develop permanent hypothyroidism and need lifelong levothyroxine [C4].

Why are antithyroid drugs not used? Subacute thyroiditis is destructive thyrotoxicosis — the gland is leaking stored hormone, not making too much new hormone. Methimazole blocks synthesis, so it has nothing to act on. A beta-blocker controls the symptoms; the leak resolves on its own [C2].

Can a "natural" anti-inflammatory replace prednisone? There is no evidence that turmeric, fish oil, herbal teas, or other supplements work in subacute thyroiditis. NSAIDs and short-course steroids are the only treatments with trial-level evidence [C2][C3].

Will subacute thyroiditis come back? Recurrence is uncommon (roughly 2% to 4%), and most often happens when steroids are tapered too quickly. Following the full taper your endocrinologist prescribes is the single best way to reduce relapse risk [C3][C5].

Bottom line

Subacute (De Quervain's) thyroiditis is a painful, post-viral granulomatous thyroiditis with a stereotyped three-phase course: thyrotoxicosis, hypothyroidism, then recovery [C1][C4]. NSAIDs are first-line for pain and inflammation, with prednisone reserved for severe or refractory cases and a beta-blocker for thyrotoxic symptoms [C2][C3][C5]. Antithyroid drugs do not work because the problem is hormone leak, not over-synthesis [C2]. About 85% to 95% of patients recover fully; roughly 5% to 15% develop permanent hypothyroidism and need long-term levothyroxine [C1][C4][C6].